Travere’s Sparsentan Faces Slower Uptake Due To Liver Monitoring Requirement

Firm Thinks Unmet Need Will Ensure Commercial Success

 
• By Alaric DeArment
Travere said its PDUFA date for sparsentan, originally 17 November, would be extended by three months • Source: Shutterstock

More from Strategy

More from Business